SCHEMBL2945192

SCHEMBL2945192

CCC(CC)n1c(=O)ccc2c(-c3ccccc3Cl)nc(N(C)C3CCNCC3)nc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.41
MAPK13 O15264 5/20 0.41
MAPK12 P53778 5/20 0.41
MAPK11 Q15759 5/20 0.41
SLC6A2 P23975 3/20 0.35
SLC6A4 P31645 3/20 0.35
SLC6A3 Q01959 3/20 0.35
KCNH2 Q12809 1/20 0.35
TSPO P30536 5/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
ALDH1A1 P00352 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
NR1I3 Q14994 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NMT1 P30419 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2945196 0.83 MAPK14 (0.42) MAPK14MAPK13MAPK12MAPK11SLC6A2
SCHEMBL5253302 0.83 MAPK14 (0.47) MAPK14MAPK13MAPK12MAPK11CHRNB2
SCHEMBL5253453 0.79 TSPO (0.39) MAPK14MAPK13MAPK12MAPK11TSPO
SCHEMBL1059061 0.74 MAPK14 (0.41) MAPK14MAPK13MAPK12MAPK11TSPO
SCHEMBL1062919 0.73 MAPK14 (0.42) MAPK14MAPK13MAPK12MAPK11TSPO
SCHEMBL1065732 0.73 MAPK14 (0.45) MAPK14MAPK13MAPK12MAPK11
SCHEMBL1061523 0.70 FGFR1 (0.40) MAPK14MAPK13MAPK12MAPK11TSPO
SCHEMBL1061548 0.70 CDK1 (0.40) MAPK14TSPOMEN1KMT2ACYP3A4
SCHEMBL1063652 0.70 PAK1 (0.35) MAPK14MAPK13MAPK12MAPK11TSPO
SCHEMBL1065513 0.70 FGFR2 (0.39) TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4524072-B2 2010-08-11 JP claimed
EP-1333833-A4 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2007-10-24 EP claimed
EP-1333833-A2 NOVEL COMPOUNDS SmithKline Beecham Corporation (US) 2003-08-13 EP claimed
WO-2002059083-A2 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2002-08-01 WO claimed
EP-1333833-A4 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2007-10-24 EP disclosed
EP-1333833-A2 NOVEL COMPOUNDS SmithKline Beecham Corporation (US) 2003-08-13 EP disclosed
WO-2002059083-A2 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2002-08-01 WO disclosed